Thought Leaders

An Introduction to High Performance Superconductors

Superconductors are a class of compounds which conduct electricity without resistance and are impermeable to magnetic flux below a critical temperature. As a result of this, they are ubiquitous in applications as diverse as MRI scanners, Earth-orbiting deep space cameras and Maglev trains.

With a worldwide market for superconducting materials predicted to be £20 billion by 2020, there is a huge research effort to discover new families of superconducting materials which may further improve performance and/or range of applications. Although systematic investigation has revealed many new superconducting compounds, some of the most spectacular discoveries owe their origins to chance.

Whilst Science awaits the warm hand of serendipity to uncover the newest superconductor, materials chemists are beginning to explore new synthetic routes to existing superconductors. In particular, it is the improvement of important physical properties such as the critical current density (Jc) which are actively being researched. The critical current density is the point at which the amount of current flowing through the superconductor causes superconductivity to be destroyed, so for practical applications the higher the Jc of the superconductor, the better.

It was found by a number of researchers that Jc was being suppressed in materials with large-angle crystal grain boundaries, leading to the conclusion that grain boundaries act as weak links in limiting the Jc of bulk high-temperature superconductors1,2. The elimination or minimization of large-angle grain boundaries by homogeneously synthesizing superconductors is therefore being pursued intensively.

Traditionally, metal oxide superconductors have been made by repeatedly grinding together metal salts and/or metal oxide powders, followed by sintering, producing largely uncontrolled crystal growth3. Instead Dr. Hall's work has focussed on the use of biopolymers to sequester metal cations, followed by in situ carbonization, both of which serve to prevent this uncontrolled growth. Once suitable solution-based syntheses had been devised for the high temperature superconductors, it was conceptually effortless for me to invoke the mechanisms of templated crystallization used by biomineralizing organisms as a means to achieving chemical and morphological homogeneity in this class of materials4-11.

The field of biomimetic materials chemistry is a powerful one, in that researchers are able not only to produce crystals which are morphologically homogeneous and more monodisperse12,13, but which either concurrently or subsequently can be ordered in a very precise manner14,15, taking as their cue the procedures and protocols adopted by biomineralizing organisms in order to produce a bewildering array of complex and intricate materials16,17.

One of the first biopolymers Dr. Hall has applied to templated superconductor growth, owing to its enormous potential to sequester metal cations is dextran. Dextran is a complex branched polysaccharide, which consists of many glucose molecules linked together in long chains of varying molecular weight from 1 kDa to over 650 kDa depending on the source. Very simply, sponges of the superconductor YBa2Cu2O7-ä (YBCO) were prepared by dissolving dextran in a solution of nitrates of yttrium, barium and copper to form a light blue, viscous paste which was allowed to solidify at room temperature. When calcined, the correct crystallinity of the superconductor was achieved; the dextran foaming as it degraded, resulting in an effective mixing and oxygenation of the superconducting phase, leading to a highly porous, monophasic material (Figure 1)18.

Superconducting YBCO sponge synthesized using dextran. Scale bar is 10 microns.
Figure 1. Superconducting YBCO sponge synthesized using dextran. Scale bar is 10 microns.

SQUID magnetometry of the sponges showed that this material was superconducting at a temperature of 90 K and that owing to the reticulated nature of the crystallites, had a critical current density that was two orders of magnitude higher than that observed in a commercially available, high-purity YBCO material. This observed morphological enhancement of Jc is in agreement with that predicted theoretically for YBCO with closely aligned crystallites19.

Another biopolymer which is showing tremendous promise is chitosan. This is simply derived from chitin, a polysaccharide which is one of the main structural components in fungi, insects and arthropods. Nature uses chitin to form complex architectural structures in many phyla, from tough crab and lobster shells, to strong yet flexible mushroom gills. Chitin molecules adopt a helical conformation, due to the presence of chiral carbon centres formed by glycosidic linkages which can subsequently pack together to form fibres and bundles of fibres. A slight modification of the reactive side groups of chitin produces chitosan.

Chitosan is non-toxic and has therefore found applications in medicine20, cosmetics21 and food technology22 due to its low cost and biocompatibility. Of particular relevance to mineralization studies is the fact that is it soluble in acidic aqueous environments and has the ability to preferentially sequester transition and post-transition metal ions from aqueous solutions23. Chitosan has been shown to be a remarkably stable biomaterial; when subjected to temperatures of 160 °C there is no apparent change of molecular configuration24. This stability makes it ideal as a template in which to perform hydrothermal syntheses without appreciable loss of template structure before nucleation and growth of the inorganic phase is initiated.

For these reasons, chitosan is an ideal templating matrix for the crystallographically controlled syntheses of YBCO superconductors. With a heating rate of 1°C/min, above 400°C nanoparticles of barium carbonate nucleate and grow, well separated in the amorphous remains of the template. Sintering of the nanoparticles was prevented by the amorphous material and thus remained as discrete centres for the subsequent outgrowth of YBCO nanowires. Nanowires were then able to grow from these 'seed' nanoparticles from around 811°C onwards.

Crystal growth proceeded along the crystallographic c-axis, leading to the formation of nanowires, all around 50nm ± 5nm in the short axis and from 600nm to over 1000nm in length (Figure 2). SQUID magnetometry of the nanowires revealed that morphology can be controlled in this manner without significant loss of superconducting performance. With their preferential crystallographic oriented growth, these nanowires should provide a better way of studying and understanding superconductivity in anisotropic systems and perhaps have the potential for incorporation into future computer circuitry.

Superconducting YBCO nanowire synthesized using chitosan. Scale bar is 200 nm.
Figure 2. Superconducting YBCO nanowire synthesized using chitosan. Scale bar is 200 nm.

References

  1. T. Tan, S. Li, J. T. Oh, W. Gao, H. K. Liu and S. X. Dou, Supercond. Sci. & Tech. 2001, 14, 78.
  2. L. Zhou, C. B. Mao, X. Z. Wu and X. Y. Sun, Supercond. Sci. & Tech. 1997, 10, 47.
  3. J. J. Rha, K. J. Yoon, S.-J. L. Kang and D. N. Yoon, J. Amer. Ceram. Soc. 1988, 71, C328.
  4. S. R. Hall et al., J. Electronic Mater. 2010, 39, 2232.
  5. S. R. Hall et al., Physica C 2010, 470, 373.
  6. S. R. Hall, Proc. Royal Soc. A. 2009, 465, 335.
  7. S. R. Hall et al., Supercond. Sci. & Tech. 2009, 22, 015026.
  8. S. R. Hall et al., Adv. Mater. 2008, 20, 1782.
  9. S. R. Hall et al., Chem. Comm. 2008, 9, 1055.
  10. S. R. Hall et al., Chem. Mater. 2007, 19, 647.
  11. S. R. Hall, Adv. Mater. 2006, 18, 487.
  12. S. R. Hall, H. Bolger and S. Mann, Chem. Comm. 2003, 22, 2784.
  13. S. R. Hall, S. A. Davis and S. Mann, Langmuir 2000, 16, 1454.
  14. S. R. Hall, W. Shenton, H. Engelhardt and S. Mann, Chemphyschem 2001, 2, 184.
  15. H. Wakayama, S. R. Hall and S. Mann, J. Mater. Chem. 2005, 15, 1134.
  16. S. R. Hall, C. E. Fowler, B. Lebaeu and S. Mann, Chem. Comm. 1999, 2, 201.
  17. S. R. Hall, et coll., J. Chem. Soc. Dalton Trans. 2000, 21, 3753.
  18. D. Walsh, S. C. Wimbush and S. R. Hall, Chem. Mater. 2007, 19, 647.
  19. J. L. MacManus-Driscoll and S. C. Wimbush, IEEE/CSC & ESAS (ESNF), No. 14, October 2010.
  20. M. Hasegawa, K. Yagi, S. Iwakawa and M. Hirai, Japan J. Cancer Res. 2001, 92, 459.
  21. P. Perugini, I. Genta, F. Pavanetto, B. Conti, S. Scalia and A. Baruffini, Int. J. Pharm. 2000, 196, 51.
  22. S. S. Koide, Nutrition Res. 1998, 18, 1091.
  23. K. Ogawa, K. Oka and T. Yui, Chem. Mater. 1993, 5, 726.
  24. M. Bengisu and E. Yilmaz, Carbohydr. Polym. 2002, 50, 165.

Disclaimer: The views expressed here are those of the interviewee and do not necessarily represent the views of AZoM.com Limited (T/A) AZoNetwork, the owner and operator of this website. This disclaimer forms part of the Terms and Conditions of use of this website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Hall, Simon. (2019, June 24). An Introduction to High Performance Superconductors. AZoM. Retrieved on September 07, 2024 from https://www.azom.com/article.aspx?ArticleID=5556.

  • MLA

    Hall, Simon. "An Introduction to High Performance Superconductors". AZoM. 07 September 2024. <https://www.azom.com/article.aspx?ArticleID=5556>.

  • Chicago

    Hall, Simon. "An Introduction to High Performance Superconductors". AZoM. https://www.azom.com/article.aspx?ArticleID=5556. (accessed September 07, 2024).

  • Harvard

    Hall, Simon. 2019. An Introduction to High Performance Superconductors. AZoM, viewed 07 September 2024, https://www.azom.com/article.aspx?ArticleID=5556.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.